PARIS – Dechert LLP assisted Bryan Garnier & Co Ltd, as global coordinator, joint lead-manager and bookrunner, and RBC Europe Limited, as joint lead-manager and bookrunner, in relation to the €16 million public offering of Biom’Up. Biom’Up is a French company that specializes in surgical hemostasis. Its flagship product aims at simplifying surgical procedures in numerous specialties.
The team advising Bryan Garnier & Co Ltd and RBC Europe Limited included Paris-based corporate partner François Hellot and corporate associates Quentin Durand and Benhouda Derradji on corporate aspects, as well as New York-based corporate partner David Rosenthal on U.S. law.
Read the press release in French (PDF): Dechert conseille Bryan Garnier & Co Ltd et RBC Europe Limited dans le cadre de l'offre au public de Biom’Up
About Dechert
Dechert is a global law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients' most important matters. Nothing stands in the way of giving clients the best of the firm's entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
